Federal
Register Notices > Notices of
Registration - 2007
>
Austin Pharma LLC,
FR Doc E7-22463 [Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices] [Page 64675] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-131]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 26, 2007, and published in the Federal Register on July
5, 2007, (72 FR 36728), Austin Pharma LLC, 811 Paloma Drive, Suite A, Round
Rock, Texas 78664, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Alphamethadol (9605)
|
I
|
Methadone (9250)
|
II
|
Methadone Intermediate (9254)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Alfentanil (9737)
|
II
|
Remifentanil (9739)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Austin Pharma LLC to
manufacture the listed basic classes of controlled substances is consistent with
the public interest at this time. DEA has investigated Austin Pharma LLC to
ensure that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's physical
security systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company
is granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-22463 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|